0 results for 'Merck'
Cross-Department Collaboration at Sullivan & Cromwell Key in Bayer's Appellate Win Over Merck
"We can handle all sorts of big problems for all sorts of big clients, rather than being very narrowly focused on narrow subject matter expertise," partner Judd Littleton said. "When we get this big dispute going to the Delaware Supreme Court, we're able to discuss it together."Meet The 2023 American Lawyer Lifetime Achievement Honorees
These honorees have made impacts on the profession and their communities that go well beyond their day-to-day practice.The American Lawyer Names Attorney of the Year, Law Firm of the Year and More
The American Lawyer Industry Awards honored the industry's best and brightest across several categories that recognize both historical excellence and the evolution of the business of law.Blackstone-Backed Music-Management Company Hires First GC
BMG veteran Jonathan Baker is taking the legal reins of Hipgnosis Song Management, which is run by former Elton John and Beyoncé manager Merck Mercuriadis.Contractual Details Shift Talc Liability to Bayer, Merck Lawyers Tell Del. Supreme Court
Merck is seeking confirmation that Bayer is liable for talc claims that have been filed against both companies since 2014, when Bayer bought product lines from Merck in a $14 billion deal. The Court of Chancery dismissed Merck's claims in April.View more book results for the query "Merck"
Merck Lawyers Tell Del. Supreme Court Contractual Details Shift Talc Liability to Bayer
Merck is seeking confirmation that Bayer is liable for talc claims that have been filed against both companies since 2014, when Bayer bought product lines from Merck in a $14 billion deal. The Court of Chancery dismissed Merck's claims in April.Senior Canadian Pharma GC Joins Fasken in Montreal
Robert Quesnel was head of legal affairs at Paris-based Sanofi for 15 before joining the national law firm.Merck, Glenmark Settle Zetia Antitrust Litigation for $70M, Including $23M in Attorney Fees
U.S. District Senior Judge Rebecca Beach Smith of the Eastern District of Virginia approved the final settlement agreement between a class of drug purchasers and pharmaceutical companies, Merck & Co., and Glenmark Pharmaceuticals, which also requires the defendants to pay one-third of the settlement fund in attorney fees, or $23 million, as well as $3.9 million in costs—as requested by plaintiffs' counsel.Zostavax Bellwether Faces Setback as Judge Nixes Key Expert
"Dr. Jeret simply references literature demonstrating that viruses such as COVID-19 or Epstein-Barr can trigger PDH. This literature, however, makes no mention of Zostavax."Trending Stories
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now